Mannkind (MNKD) Amortization - Intangibles (2026)

Mannkind's (MNKD) quarterly Amortization - Intangibles came in at $4.4 million in Q1 2026.

Mannkind (MNKD) Amortization - Intangibles (2026) Analysis & Trends

Mannkind (MNKD) has 1 years of Amortization - Intangibles data on file, last reported at $4.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.37 Mn